23 research outputs found
Effects of Amino Acid Additives on Protein Stability during Electrothermal Supercharging in ESI-MS
The surprising formation of highly charged protein ions
from aqueous
ammonium bicarbonate solution is a fascinating phenomenon referred
to as electrothermal supercharging (ETS). Although the precise mechanism
involved is not clearly understood, previous studies predominantly
suggest that ETS is due to native protein destabilization in the presence
of bicarbonate anion inside the electrospray ionization droplets under
high temperatures and spray voltages. To evaluate existing hypotheses
surrounding the underlying mechanism of ETS, the effects of several
additives on protein charging under ETS conditions were investigated.
The changes in the protein charge state distributions were compared
by measuring the ratios between the intensities of highest
intensity charge states of native and unfolded protein envelopes
and shifts in the lowest and highest observed charge states. This study demonstrated that source temperature plays a more important
role in ETS compared to spray voltage, especially when using a nebulized
microelectrospray ionization source. Moreover, the effect of amino
acids on ETS were generally in good agreement with the extensive literature
available on the stabilization or destabilization of proteins by these
additives in bulk solution. Among the natural amino acids, protein
supercharging was significantly reduced by proline and glycine; however,
imidazole provided the highest degree of noncovalent complex stabilization
against ETS, outperforming the amino acids. Overall, our study shows
that the simple addition of stabilizing reagents such as proline and
imidazole can reduce the extent of apparent protein unfolding and
supercharging in ammonium bicarbonate solution and provide evidence
against the roles of charge depletion and thermal unfolding during
ETS
Endogenous Protein–Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex
NPC intracellular cholesterol transporter 1 (NPC1) is
a multipass,
transmembrane glycoprotein mostly recognized for its key role in facilitating
cholesterol efflux. Mutations in the NPC1 gene result
in Niemann-Pick disease, type C (NPC), a fatal, lysosomal storage
disease. Due to the progressively expanding implications of NPC1-related
disorders, we investigated endogenous NPC1 protein–protein
interactions in the mouse cortex and human-derived iPSCs neuronal
models of the disease through coimmunoprecipitation-coupled with LC-MS
based proteomics. The current study investigated protein–protein
interactions specific to the wild-type and the most prevalent NPC1
mutation (NPC1I1061T) while filtering out any protein interactor
identified in the Npc1–/– mouse model. Additionally, the results were matched across
the two species to map the parallel interactome of wild-type and mutant
NPC1I1061T. Most of the identified wild-type NPC1 interactors
were related to cytoskeleton organization, synaptic vesicle activity,
and translation. We found many putative NPC1 interactors not previously
reported, including two SCAR/WAVE complex proteins that regulate ARP
2/3 complex actin nucleation and multiple membrane proteins important
for neuronal activity at synapse. Moreover, we identified proteins
important in trafficking specific to wild-type and mutant NPC1I1061T. Together, the findings are essential for a comprehensive
understanding of NPC1 biological functions in addition to its classical
role in sterol efflux
Endogenous Protein–Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex
NPC intracellular cholesterol transporter 1 (NPC1) is
a multipass,
transmembrane glycoprotein mostly recognized for its key role in facilitating
cholesterol efflux. Mutations in the NPC1 gene result
in Niemann-Pick disease, type C (NPC), a fatal, lysosomal storage
disease. Due to the progressively expanding implications of NPC1-related
disorders, we investigated endogenous NPC1 protein–protein
interactions in the mouse cortex and human-derived iPSCs neuronal
models of the disease through coimmunoprecipitation-coupled with LC-MS
based proteomics. The current study investigated protein–protein
interactions specific to the wild-type and the most prevalent NPC1
mutation (NPC1I1061T) while filtering out any protein interactor
identified in the Npc1–/– mouse model. Additionally, the results were matched across
the two species to map the parallel interactome of wild-type and mutant
NPC1I1061T. Most of the identified wild-type NPC1 interactors
were related to cytoskeleton organization, synaptic vesicle activity,
and translation. We found many putative NPC1 interactors not previously
reported, including two SCAR/WAVE complex proteins that regulate ARP
2/3 complex actin nucleation and multiple membrane proteins important
for neuronal activity at synapse. Moreover, we identified proteins
important in trafficking specific to wild-type and mutant NPC1I1061T. Together, the findings are essential for a comprehensive
understanding of NPC1 biological functions in addition to its classical
role in sterol efflux
Endogenous Protein–Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex
NPC intracellular cholesterol transporter 1 (NPC1) is
a multipass,
transmembrane glycoprotein mostly recognized for its key role in facilitating
cholesterol efflux. Mutations in the NPC1 gene result
in Niemann-Pick disease, type C (NPC), a fatal, lysosomal storage
disease. Due to the progressively expanding implications of NPC1-related
disorders, we investigated endogenous NPC1 protein–protein
interactions in the mouse cortex and human-derived iPSCs neuronal
models of the disease through coimmunoprecipitation-coupled with LC-MS
based proteomics. The current study investigated protein–protein
interactions specific to the wild-type and the most prevalent NPC1
mutation (NPC1I1061T) while filtering out any protein interactor
identified in the Npc1–/– mouse model. Additionally, the results were matched across
the two species to map the parallel interactome of wild-type and mutant
NPC1I1061T. Most of the identified wild-type NPC1 interactors
were related to cytoskeleton organization, synaptic vesicle activity,
and translation. We found many putative NPC1 interactors not previously
reported, including two SCAR/WAVE complex proteins that regulate ARP
2/3 complex actin nucleation and multiple membrane proteins important
for neuronal activity at synapse. Moreover, we identified proteins
important in trafficking specific to wild-type and mutant NPC1I1061T. Together, the findings are essential for a comprehensive
understanding of NPC1 biological functions in addition to its classical
role in sterol efflux
Endogenous Protein–Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex
NPC intracellular cholesterol transporter 1 (NPC1) is
a multipass,
transmembrane glycoprotein mostly recognized for its key role in facilitating
cholesterol efflux. Mutations in the NPC1 gene result
in Niemann-Pick disease, type C (NPC), a fatal, lysosomal storage
disease. Due to the progressively expanding implications of NPC1-related
disorders, we investigated endogenous NPC1 protein–protein
interactions in the mouse cortex and human-derived iPSCs neuronal
models of the disease through coimmunoprecipitation-coupled with LC-MS
based proteomics. The current study investigated protein–protein
interactions specific to the wild-type and the most prevalent NPC1
mutation (NPC1I1061T) while filtering out any protein interactor
identified in the Npc1–/– mouse model. Additionally, the results were matched across
the two species to map the parallel interactome of wild-type and mutant
NPC1I1061T. Most of the identified wild-type NPC1 interactors
were related to cytoskeleton organization, synaptic vesicle activity,
and translation. We found many putative NPC1 interactors not previously
reported, including two SCAR/WAVE complex proteins that regulate ARP
2/3 complex actin nucleation and multiple membrane proteins important
for neuronal activity at synapse. Moreover, we identified proteins
important in trafficking specific to wild-type and mutant NPC1I1061T. Together, the findings are essential for a comprehensive
understanding of NPC1 biological functions in addition to its classical
role in sterol efflux
Endogenous Protein–Protein Interaction Network of the NPC Cholesterol Transporter 1 in the Cerebral Cortex
NPC intracellular cholesterol transporter 1 (NPC1) is
a multipass,
transmembrane glycoprotein mostly recognized for its key role in facilitating
cholesterol efflux. Mutations in the NPC1 gene result
in Niemann-Pick disease, type C (NPC), a fatal, lysosomal storage
disease. Due to the progressively expanding implications of NPC1-related
disorders, we investigated endogenous NPC1 protein–protein
interactions in the mouse cortex and human-derived iPSCs neuronal
models of the disease through coimmunoprecipitation-coupled with LC-MS
based proteomics. The current study investigated protein–protein
interactions specific to the wild-type and the most prevalent NPC1
mutation (NPC1I1061T) while filtering out any protein interactor
identified in the Npc1–/– mouse model. Additionally, the results were matched across
the two species to map the parallel interactome of wild-type and mutant
NPC1I1061T. Most of the identified wild-type NPC1 interactors
were related to cytoskeleton organization, synaptic vesicle activity,
and translation. We found many putative NPC1 interactors not previously
reported, including two SCAR/WAVE complex proteins that regulate ARP
2/3 complex actin nucleation and multiple membrane proteins important
for neuronal activity at synapse. Moreover, we identified proteins
important in trafficking specific to wild-type and mutant NPC1I1061T. Together, the findings are essential for a comprehensive
understanding of NPC1 biological functions in addition to its classical
role in sterol efflux